FAP and pancreatic adenocarcinoma: Accordingly, a clinical investigation used (177)Lu-FAP-2286 in 11 patients with advanced adenocarcinomas of the pancreas, breast, rectum, and ovary after prior confirmation of uptake on (68)Ga-FAP-2286/-FAPI-04- PET/CT.